When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alcohol-related liver disease

Evidence last reviewed: 12 Feb 2026
Topic last updated: 10 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • abdominal pain
  • hepatomegaly
  • hematemesis and melena
  • venous collaterals
  • splenomegaly
  • hepatic mass
  • jaundice
  • palmar erythema
  • cutaneous telangiectasia
  • asterixis
Full details

Other diagnostic factors

  • ascites
  • weight loss
  • weight gain
  • malnutrition and wasting
  • anorexia
  • fatigue
  • confusion
  • pruritus
  • fever
  • nausea and vomiting
  • finger clubbing
  • Dupuytren contracture
  • leg swelling
  • parotid gland enlargement
  • gynecomastia
  • hypogonadism
  • dementia
  • peripheral neuropathy
Full details

Risk factors

  • prolonged and heavy alcohol consumption
  • hepatitis C
  • female sex
  • cigarette smoking
  • obesity
  • age >65 years
  • Hispanic ethnicity
  • genetic predisposition
Full details

Diagnostic investigations

1st investigations to order

  • serum aspartate aminotransferase (AST), alanine aminotransferase (ALT)
  • serum AST/ALT ratio
  • serum alkaline phosphatase
  • serum bilirubin
  • serum albumin, protein
  • serum gamma glutamyl transferase (gamma-GT)
  • CBC
  • serum electrolytes, magnesium, phosphorus
  • serum BUN and creatinine
  • serum prothrombin time (PT), INR
  • hepatic ultrasound
Full details

Investigations to consider

  • viral hepatitis serology
  • serum iron, ferritin, transferrin
  • urine copper (24-hour collection)
  • serum ceruloplasmin
  • serum antimitochondrial antibody (AMA)
  • serum antinuclear antibody (ANA) and antismooth muscle antibody (ASMA)
  • serum alpha-1 antitrypsin level
  • serum ammonia
  • serum folate
  • noninvasive tests of liver elasticity
  • CT abdomen, MRI abdomen
  • liver biopsy
Full details

Emerging tests

  • serum carbohydrate-deficient transferrin test
  • serum mitochondrial AST
  • Phosphatidylethanol (PEth)

Treatment algorithm

ONGOING

all patients

Contributors

Authors

Craig McClain, MD
Craig McClain

Professor

Chief of Research Affairs

Associate Vice President for Health Affairs/Research

Division of Gastroenterology, Hepatology and Nutrition

Department of Medicine

University of Louisville School of Medicine

Louisville

KY

Disclosures

CM receives contract research support from the National Institutes of Health, the Veterans Administration, and Target Pharma Solutions.

Luis Marsano, MD
Luis Marsano

Professor and Director of Hepatology

Division of Gastroenterology, Hepatology and Nutrition

Department of Medicine

University of Louisville School of Medicine

Louisville

KY

Disclosures

LM declares that he has no competing interests.

Acknowledgements

Dr Craig McClain and Dr Luis Marsano would like to gratefully acknowledge Dr Mihir Patel, a previous contributor to this topic.

Disclosures

MP declares that he has no competing interests.

Peer reviewers

Lorenzo Leggio, MD, MSc

Postdoctoral Research Associate

Center for Alcohol and Addiction Studies

Brown University

Providence

RI

Disclosures

LL declares that he has no competing interests.

Nancy Reau, MD

Assistant Professor of Medicine

University of Chicago

Center for Liver Disease

Chicago

IL

გაფრთხილება:

NR declares that she has no competing interests.

Nick Sheron, MD, FRCP

Head of Clinical Hepatology and Senior Lecturer

Division of Infection, Inflammation and Immunity

University of Southampton Medical School

Southampton General Hospital NHS Trust

Southampton

UK

გაფრთხილება:

NS has received research grants from the Medical Research Council (MRC), Wellcome Trust, British Liver Trust, Alcohol Education Research Council, and various other funding bodies. He has undertaken paid consultancy work and received traveling expenses from pharmaceutical companies developing drugs for the treatment of inflammatory bowel disease and liver disease. He has been paid for medico-legal work in the areas of hepatitis C and alcohol-related liver disease. The following memberships and advisory work are unpaid apart from traveling expenses: EU Alcohol Forum, EU Alcohol Marketing Taskforce, Royal College of Physicians Alcohol Committee, Alcohol Health Alliance UK. NS has undertaken advisory and media work for the UK Department of Health, Home Office, Department of Transport, Cross Cabinet Strategy Committee, National Institute for Health and Care Excellence, Southampton City Council, UK Police, and British Liver Trust, and various other NGOs, local government, and other bodies. NS is an unpaid trustee of the Drinkaware Trust, an independent body set up by the UK Government to use industry resources to reduce alcohol-related harm. The Trust is funded entirely by the alcohol industry, with a board of trustees comprising 5 industry members, 5 members with alcohol-related health expertise, and 3 lay members.

Alastair MacGilchrist, MD, FRCP

Consultant Hepatologist

Royal Infirmary of Edinburgh

Edinburgh

UK

გაფრთხილება:

AM declares that he has no competing interests.

რეცენზენტების განცხადებები

BMJ Best Practice-ის თემების განახლება სხვადასხვა პერიოდულობით ხდება მტკიცებულებებისა და რეკომენდაციების განვითარების შესაბამისად. ქვემოთ ჩამოთვლილმა რეცენზენტებმა თემის არსებობის მანძილზე კონტენტს ერთხელ მაინც გადახედეს.

გაფრთხილება

რეცენზენტების აფილიაციები და გაფრთხილებები მოცემულია გადახედვის მომენტისთვის.

წყაროები

ჩვენი მტკიცებულებებისა და სარედაქციო ჯგუფები თანამშრომლობენ საერთაშორისო ექსპერტებსა და რეცენზენტებთან, რათა უზრუნველვყოთ თქვენი წვდომა კლინიკურად ყველაზე მნიშვნელოვან ინფორმაციაზე.

ძირითადი სტატიები

Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: alcohol-associated liver disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54.სრული ტექსტი  აბსტრაქტი

Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.სრული ტექსტი  აბსტრაქტი

გამოყენებული სტატიები

ამ თემაში მოხსენიებული წყაროების სრული სია ხელმისაწვდომია მომხმარებლებისთვის, რომლებსაც აქვთ წვდომა BMJ Best Practice-ის ყველა ნაწილზე.
  • Alcohol-related liver disease images
  • დიფერენციული დიაგნოზები

    • Hepatitis B virus (HBV) infection
    • Hepatitis C virus (HCV) infection
    • Hepatitis A virus infection
    მეტი დიფერენციული დიაგნოზები
  • გაიდლაინები

    • AASLD Practice Guideline on non-invasive liver disease assessments of portal hypertension​
    • ACG clinical guideline: alcohol-associated liver disease
    მეტი გაიდლაინები
  • პაციენტის ბროშურები

    Alcoholic liver disease

    Hepatitis B: should I have the vaccine?

    მეტი პაციენტის ბროშურები
  • კალკულატორები

    Alcohol Consumption Screening AUDIT Questionnaire

    Modified Maddrey's Discriminant Function

    მეტი კალკულატორები
  • Videos

    Abdominal paracentesis animated demonstration

    მეტი ვიდეოები
  • padlock-lockedშედით სისტემაში ან გამოიწერეთ BMJ Best Practice

ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას